Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Current Deferred Revenue (2009 - 2026)

Evotec SE's (EVO) quarterly Current Deferred Revenue came in at $79.5 million in Q2 2026, down 47.02% year-over-year from $150.1 million in Q2 2025, and down 39.21% quarter-over-quarter from $130.8 million in Q1 2026.

Analysis

Evotec SE (EVO) Current Deferred Revenue (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Current Deferred Revenue across 10 years of filings, most recently posting $79.5 million for Q2 2026.

  • In Q2 2026, Current Deferred Revenue fell 47.02% year-over-year to $79.5 million; the TTM figure through Jun 2026 stood at $79.5 million (down 47.02% YoY), while the FY2025 annual figure was $118.5 million, up 2.67% from the prior year.
  • Current Deferred Revenue came in at $79.5 million for Q2 2026 at Evotec SE, down from $130.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $151.2 million in Q2 2023 to a low of -$143.0 million in Q2 2022.
  • Average Current Deferred Revenue over 5 years is $104.3 million, with a median of $125.1 million recorded in 2022.
  • Year-over-year, Current Deferred Revenue soared 205.8% in 2023 and plunged 47.02% in 2026.
  • Over 5 years, Current Deferred Revenue stood at $125.4 million in 2022, then dropped by 16.28% to $105.0 million in 2023, then increased by 8.49% to $113.9 million in 2024, then climbed by 7.14% to $122.0 million in 2025, then slumped by 34.84% to $79.5 million in 2026.
  • Per Business Quant data, the three most recent Current Deferred Revenue figures were $79.5 million in Q2 2026, $130.8 million in Q1 2026, and $122.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn
6 Evotec SE 642.83 Mn 216.96 Mn -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.52 Mn
Mar 31, 2026 130.81 Mn
Dec 31, 2025 122.05 Mn
Sep 30, 2025 124.89 Mn
Jun 30, 2025 150.09 Mn
Mar 31, 2025 132.29 Mn
Dec 31, 2024 113.91 Mn
Sep 30, 2024 108.38 Mn
Dec 31, 2023 105.00 Mn
Jun 30, 2023 151.24 Mn
Dec 31, 2022 125.41 Mn
Sep 30, 2022 133.49 Mn
Jun 30, 2022 -142.95 Mn
Mar 31, 2022 126.67 Mn
Dec 31, 2021 128.19 Mn
Sep 30, 2021 71.60 Mn
Dec 31, 2020 -17.43 Mn
Dec 31, 2019 -16.25 Mn
Sep 30, 2010 6.23 Mn
Jun 30, 2010 6.32 Mn